Several stocks remain undervalued with upside potential above 25% based on fair value.
Merck, First Solar, and AMD stand out as top picks for gains in 2025.
Looking for actionable trade ideas to navigate the current market volatility? Subscribe here to unlock access to InvestingPro’s AI-selected stock winners.
Late last year, I shared 10 stocks, including five in , that analysts rated as “Strong Buys” based on their value, momentum, growth potential, and industry trends. Now that 2025 is in full swing, it is time to review: which stocks have already delivered returns, and which ones are still flying under the radar but might surprise us by the end of the year?
Based on the latest data, only 2 out of the 10 stocks have delivered positive returns since the start of the year.
The rest are still trading below their early January levels. Some, like Merck (NSE:) with a -21.7% drop, are feeling the impact of sector-wide pressure, while others are going through periods of technical consolidation. However, earnings forecasts and fair value estimates suggest there could be more to come.
Stocks That Have Already Shone (but are not necessarily done):
Uber led the way in the first half of the year, driven by strong revenue growth, progress in autonomous vehicles, and a sharper focus on retail.
Micron rode the wave of AI enthusiasm and continues to show strong earnings growth potential.
Stocks That Can Surprise in the 2nd Half of 2025:
has the highest upside on fair value (+45.5%) and is still undervalued.
, , and offer a mix of attractive valuations and strong growth outlook.
remains a leading pharma stock, worth watching for a possible re-entry on any pullback.
Analysis of the 10 Stocks:
1. Micron Technology Inc
Micron is the perfect example of how the market does not always price growth right away. With an estimated +912% EPS growth in 2025, the stock is riding the AI boom and demand for HBM (High Bandwidth (NASDAQ:) Memory).
Price: $98.09 – YTD: +17.4% – Upside PV: +15.8%
Personal Note: Buy on weakness – great entry into pullbacks, strong potential.
2. First Solar Inc
The green sector has lost momentum, but First Solar has solid fundamentals and one of the highest upside in the group (+30%). Goldman Sachs lists it among top picks.
3. Advanced Micro Devices Inc
AMD is a pure bet on AI. It has EPS growth estimates at +293.4%, with guidance between $7-9B in 2025. The stock is still in negative territory, but the fundamentals are worth watching.
Price: $114.74 – YTD: -5.0% – Upside PV: +52.3%.
Personal note: Selective buy – excellent AI outlook, but to be managed patiently.
4. Schlumberger NV
Oil services giant Schlumberger NV (NYSE:) suffers short-term weakness, but remains undervalued with P/E fwd of 10.8x and upside of 17.7%.
5. Coterra Energy Inc
Pure “value” stock Coterra Energy, with P/E fwd below 10x and EPS Growth estimated at +81.5%. The 27.5% upside makes it attractive for those seeking yield and stability in the energy sector.
6. Merck & Company Inc
The absolute most undervalued stock in the group is Merck & Company Inc: -21.7% since start of year, but +45.5% estimated upside. Excellent dividend and solid pipeline, but dependence on Keytruda weighs.
Price: $77.55 – P/E fwd: 8.5x
Personal note: Buy for value – limited risk, high potential.
7. Uber Technologies Inc
At +53.3% YTD, Uber has already run strong. Strong in fundamentals, but upside on fair value is now negative (-5.4%), imposing caution.
Price: $93.49 – EPS Growth 2025: -21.9%.
Personal Note: Buy on strength – excellent momentum stock, but to be managed with trailing stop.
8. Constellation Brands Inc Class A
Despite Berkshire Hathaway’s (NYSE:) support, Constellation Brands (NYSE:) is still down YTD (-11.7%), with modest upside (1.8%). EPS is expected to recover, but margins under pressure.
9. Alphabet
Alphabet Inc Class A (NASDAQ:) remains one of my favorite “defensive” tech stocks. P/E fwd of 17.4x, interesting upside, with focus on evolving AI.
10. Eli Lilly and Company
Eli Lilly and Company is one of the pharma stocks with the strongest expected EPS growth (+86%), driven by obesity and diabetes drugs. However, the price is already pulled, with negative upside (-3.8%).
The first half of 2025 spotlighted two leaders, Uber and Micron, but the real opportunity might lie in stocks that have fallen behind yet have strong fundamentals and attractive valuations.
My “Top picks” to Monitor for the 2nd Half of 2025:
Merck – maximum upside, ideal defensive
First Solar – undervalued green
AMD – AI potential yet to be expressed
Be sure to check out InvestingPro to stay in sync with the market trend and what it means for your trading. Whether you’re a novice investor or a seasoned trader, leveraging InvestingPro can unlock a world of investment opportunities while minimizing risks amid the challenging market backdrop.
Subscribe now and instantly unlock access to several market-beating features, including:
ProPicks AI: AI-selected stock winners with a proven track record.
InvestingPro Fair Value: Instantly find out if a stock is underpriced or overvalued.
Advanced Stock Screener: Search for the best stocks based on hundreds of selected filters and criteria.
Top Ideas: See what stocks billionaire investors such as Warren Buffett, Michael Burry, and George Soros are buying.
****Disclaimer: This article is written for informational purposes only; it does not constitute a solicitation, offer, advice, counseling or recommendation to invest as such it is not intended to incentivize the purchase of assets in any way. I would like to remind you that any type of asset, is evaluated from multiple points of view and is highly risky and therefore, any investment decision and the associated risk remains with the investor.”
